Refractory Malignant Brain Neoplasm

1 clinical trials · Condition

Record	Firm	Date
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children (NCT04510051)	City of Hope Medical Center	2020-12-04

Every clearance here is in the API, with alerts when new ones post.